Epileptic seizures are one of the more frequently overlooked comorbidities in multiple sclerosis (MS). Recent studies have shown that the rate of epilepsy among MS patients is about twice as high, suggesting that the inflammatory and demyelination processes of MS itself promote epileptogenic mechanisms.
Autoren
- Tanja Schliebe
Publikation
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- Prurigo nodularis: evidence-based treatment
Targeted therapy options on the rise
- MACE risk, heart failure incidence and all-cause mortality
Metabolic syndrome as a cardiovascular risk factor
- Glaucoma in old age: slowing down progression
IOP lowering is currently the only evidence-based treatment
- Vector-borne infections with skin manifestations
Arboviruses and leishmaniasis in Europe
- Multimorbidity and functional capacity in old age
Clarify individual health status and reduce risks
- Tick season: danger from early summer meningoencephalitis
TBE vaccination recommended for adults and children aged 3 and over
- New WHO guideline, updated stimulation protocols, focus on PGT-A
Fertility and reproductive medicine 2026
- Proteins in wound healing